These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35992814)

  • 1. Comprehensive analyses unveil novel genomic and immunological characteristics of micropapillary pattern in lung adenocarcinoma.
    Huo Y; Sun L; Yuan J; Zhang H; Zhang Z; Zhang L; Huang W; Sun X; Tang Z; Feng Y; Mo H; Yang Z; Zhang C; Yu Z; Yue D; Zhang B; Wang C
    Front Oncol; 2022; 12():931209. PubMed ID: 35992814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-Exome Sequencing and Experimental Validation Unveil the Roles of TMEM229A Q200del Mutation in Lung Adenocarcinoma.
    Liang YX; Xie YP; Yu HM; Zhu WJ; Yin CY; Dong ZH; Zhang XL
    Clin Respir J; 2024 Aug; 18(8):e70006. PubMed ID: 39188060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatial whole exome sequencing reveals the genetic features of highly-aggressive components in lung adenocarcinoma.
    Li J; Xiong S; He P; Liang P; Li C; Zhong R; Cai X; Xie Z; Liu J; Cheng B; Chen Z; Liang H; Lao S; Chen Z; Shi J; Li F; Feng Y; Huo Z; Deng H; Yu Z; Wang H; Zhan S; Xiang Y; Wang H; Zheng Y; Lin X; He J; Liang W
    Neoplasia; 2024 Aug; 54():101013. PubMed ID: 38850835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Underlying Tumor Genomics of Predominant Histologic Subtypes in Lung Adenocarcinoma.
    Caso R; Sanchez-Vega F; Tan KS; Mastrogiacomo B; Zhou J; Jones GD; Nguyen B; Schultz N; Connolly JG; Brandt WS; Bott MJ; Rocco G; Molena D; Isbell JM; Liu Y; Mayo MW; Adusumilli PS; Travis WD; Jones DR
    J Thorac Oncol; 2020 Dec; 15(12):1844-1856. PubMed ID: 32791233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
    Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
    Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep sequencing reveals the genomic characteristics of lung adenocarcinoma presenting as ground-glass nodules (GGNs).
    Wu N; Liu S; Li J; Hu Z; Yan S; Duan H; Wu D; Ma Y; Li S; Wang X; Wang Y; Li X; Lu X
    Transl Lung Cancer Res; 2021 Mar; 10(3):1239-1255. PubMed ID: 33889506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-Exome Sequencing Reveals the Genomic Features of the Micropapillary Component in Ground-Glass Opacities.
    Meng F; Zhang Y; Wang S; Liu T; Sun M; Zhu H; Dong G; Xia Z; You J; Kong X; Wu J; Chen P; Yuan F; Yu X; Xu Y; Xu L; Yin R
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma.
    Zhao Y; Gao Y; Xu X; Zhou J; Wang H
    BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of lepidic and micropapillary/solid pathological patterns as minor components has prognostic value in patients with intermediate-grade invasive lung adenocarcinoma.
    Hou Y; Song W; Chen M; Zhang J; Luo Q; Um SW; Facchinetti F; Bongiolatti S; Zhou Q
    Transl Lung Cancer Res; 2022 Jan; 11(1):64-74. PubMed ID: 35242628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
    Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
    PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma.
    Li Z; Li F; Pan C; He Z; Pan X; Zhu Q; Wu W; Chen L
    Lung Cancer; 2021 Apr; 154():69-75. PubMed ID: 33626488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of survival and EGFR mutation with predominant histologic subtype according to the new lung adenocarcinoma classification in stage IB patients.
    Sun Y; Yu X; Shi X; Hong W; Zhao J; Shi L
    World J Surg Oncol; 2014 May; 12():148. PubMed ID: 24885205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.
    Motoi N; Szoke J; Riely GJ; Seshan VE; Kris MG; Rusch VW; Gerald WL; Travis WD
    Am J Surg Pathol; 2008 Jun; 32(6):810-27. PubMed ID: 18391747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
    Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
    Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome sequencing (WES) analysis of transformed small cell lung cancer (SCLC) from lung adenocarcinoma (LUAD).
    Xie T; Li Y; Ying J; Cai W; Li J; Lee KY; Ricciuti B; Pacheco J; Xing P
    Transl Lung Cancer Res; 2020 Dec; 9(6):2428-2439. PubMed ID: 33489804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High incidence of EGFR mutations in Korean men smokers with no intratumoral heterogeneity of lung adenocarcinomas: correlation with histologic subtypes, EGFR/TTF-1 expressions, and clinical features.
    Sun PL; Seol H; Lee HJ; Yoo SB; Kim H; Xu X; Jheon S; Lee CT; Lee JS; Chung JH
    J Thorac Oncol; 2012 Feb; 7(2):323-30. PubMed ID: 22237264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma.
    Suzuki M; Matsumoto Y; Imabayashi T; Teishikata T; Tsuchida T; Asamura H; Yatabe Y
    Lung Cancer; 2021 Dec; 162():147-153. PubMed ID: 34814012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micropapillary pattern is associated with the development of brain metastases and the reduction of survival time in EGFR-mutation lung adenocarcinoma patients with surgery.
    Li C; Shen Y; Hu F; Chu T; Yang X; Shao J; Zheng X; Xu J; Zhang H; Han B; Zhong H; Zhang X
    Lung Cancer; 2020 Mar; 141():72-77. PubMed ID: 31955003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous recombination deficiency (HRD) can predict the therapeutic outcomes of immuno-neoadjuvant therapy in NSCLC patients.
    Zhou Z; Ding Z; Yuan J; Shen S; Jian H; Tan Q; Yang Y; Chen Z; Luo Q; Cheng X; Yu Y; Niu X; Qian L; Chen X; Gu L; Liu R; Ma S; Huang J; Chen T; Li Z; Ji W; Song L; Shen L; Jiang L; Yu Z; Zhang C; Tai Z; Wang C; Chen R; Carbone DP; Xia X; Lu S
    J Hematol Oncol; 2022 May; 15(1):62. PubMed ID: 35585646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.